Annals of vascular surgery · 2026
Effect of Virtual Reality Distraction on Pain and Anxiety During Peripheral Arterial Angioplasty: A Randomized Prospective Study.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yılmaz Üzeyir, Kaya Mehmet Fatih, Tekin Kudret Atakan
Аннотация
BACKGROUND: To evaluate the effect of virtual reality (VR) distraction on pain, anxiety, agitation, and physiological stress during awake peripheral arterial angioplasty. Prospective, triple-blind, randomized controlled trial.
METHODS: Adult patients undergoing elective lower-extremity angiography with planned balloon angioplasty under local anesthesia were randomized 1:1 to VR distraction or standard care. All participants wore the same headset; the control group viewed a static neutral panorama, whereas the VR group received immersive nature-based audiovisual content. Pain (visual analog scale (VAS)), anxiety (State-Trait Anxiety Inventory (STAI)-6), agitation (positive Richmond Agitation-Sedation Scale (RASS)), heart rate and blood pressure, and satisfaction were assessed during the procedure. Blinding was maintained for participants, outcome assessor, and analyst.
RESULTS: A total of 120 patients were analyzed (60 per group). VR significantly reduced intraprocedural pain (VAS 6.23 ± 0.91 vs 8.03 ± 0.94; P < 0.001) and anxiety (STAI-6 47.60 ± 7.42 vs. 67.97 ± 9.95; P < 0.001). Heart rate (P = 0.002) and systolic (P = 0.045) and diastolic (P = 0.011) blood pressures were lower in the VR group. Agitation was reduced (positive RASS 0.97 ± 0.80 vs 1.32 ± 0.83; P = 0.022). No adverse events requiring discontinuation occurred after randomization.
CONCLUSION: VR is a safe, well-tolerated, nonpharmacological adjunct that reduces pain, anxiety, agitation, and physiological stress during awake peripheral arterial angioplasty and may enhance patient cooperation without sedatives.
METHODS: Adult patients undergoing elective lower-extremity angiography with planned balloon angioplasty under local anesthesia were randomized 1:1 to VR distraction or standard care. All participants wore the same headset; the control group viewed a static neutral panorama, whereas the VR group received immersive nature-based audiovisual content. Pain (visual analog scale (VAS)), anxiety (State-Trait Anxiety Inventory (STAI)-6), agitation (positive Richmond Agitation-Sedation Scale (RASS)), heart rate and blood pressure, and satisfaction were assessed during the procedure. Blinding was maintained for participants, outcome assessor, and analyst.
RESULTS: A total of 120 patients were analyzed (60 per group). VR significantly reduced intraprocedural pain (VAS 6.23 ± 0.91 vs 8.03 ± 0.94; P < 0.001) and anxiety (STAI-6 47.60 ± 7.42 vs. 67.97 ± 9.95; P < 0.001). Heart rate (P = 0.002) and systolic (P = 0.045) and diastolic (P = 0.011) blood pressures were lower in the VR group. Agitation was reduced (positive RASS 0.97 ± 0.80 vs 1.32 ± 0.83; P = 0.022). No adverse events requiring discontinuation occurred after randomization.
CONCLUSION: VR is a safe, well-tolerated, nonpharmacological adjunct that reduces pain, anxiety, agitation, and physiological stress during awake peripheral arterial angioplasty and may enhance patient cooperation without sedatives.
Предметные рубрики MeSH
HumansProspective StudiesFemaleAnxietyMaleAgedPain MeasurementTreatment OutcomeMiddle AgedAngioplasty, BalloonPeripheral Arterial DiseaseProcedural PainHeart RateTime FactorsVirtual Reality Exposure TherapyBlood PressurePatient SatisfactionVirtual RealityStress, PhysiologicalPain PerceptionPain Management